Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Roche Diagnostics stellt Prototyp eines Endotrophin-Forschungstests bei Nordic Bioscience zur Verfügung.

      • USA - English
      • USA - Français
      • USA - English
      • USA - español
      • Japan - Japanese
      Nordic Bioscience logo

      News provided by

      Nordic Bioscience

      Nov 17, 2026, 06:48 ET

      Share this article

      Share this article


      HERLEV, Dänemark, 17. November 2026 /PRNewswire/ -- Nordic Bioscience freut sich bekannt zu geben, dass Roche Diagnostics seinen Endotrophin (ETP) Forschungsprototypentest auf seinen cobas® e801 Analyzern im CLIA-Labor von Nordic Bioscience zur Verfügung stellt.

      Continue Reading
      Roche cobas® e 801 analyzer at Nordic Bioscience's laboratory, where Roche Diagnostics is making its Endotrophin (ETP) research prototype assay available.
      Roche cobas® e 801 analyzer at Nordic Bioscience's laboratory, where Roche Diagnostics is making its Endotrophin (ETP) research prototype assay available.

      Der Endotrophin-Assay ist ein Sandwich-Immunoassay, der das intakte 77 Aminosäuren umfassende Endotrophin-Hormon quantifiziert – das Signal-Propeptid, das bei der Bildung von Kollagen Typ VI freigesetzt wird. Endotrophin steht im Zusammenhang mit Fibrose, Entzündungen und negativen Folgen bei Herz-Kreislauf-, Nieren- und Stoffwechselerkrankungen.

      Endotrophin ist der zweite Biomarker aus der Zusammenarbeit zwischen Nordic Bioscience und Roche Diagnostics, der auf der Roche-Plattform verfügbar ist, nach der Markteinführung von Elecsys® PRO-C3, der als CE-gekennzeichneter Test erhältlich ist.

      Endotrophin wurde bei mehr als 50.000 Patienten mit kardiorenal-metabolischem Syndrom gemessen. Erhöhte Endotrophinwerte wurden mit Mortalität und negativen Folgen bei Herzinsuffizienz mit erhaltener Ejektionsfraktion (HFpEF) in Verbindung gebracht, und die FDA hat ein Unterstützungsschreiben für die weitere Erforschung von Endotrophin als Anreicherungsinstrument in klinischen Studien bei HFpEF herausgegeben. Endotrophin erfasst das fibroinflammatorische Risiko über PREVENT und NT-proBNP[1] hinaus. Bei chronischer Nierenerkrankung sind die Endotrophinwerte mit zunehmender Krankheitsaktivität deutlich erhöht; hohe Werte sagen einen Rückgang der eGFR voraus, und Veränderungen des Endotrophins spiegeln Veränderungen der Nierenfunktion wider.

      Endotrophin ist mehr als nur ein Risikomarker. Mendelsche Randomisierungsstudien bringen Endotrophin ursächlich mit koronarer Herzkrankheit in Verbindung, Knockout-Modelle zeigen Schutz vor Nierenfibrose und Verlust der Nierenfunktion, und CD44 wurde als Endotrophin-Rezeptor identifiziert.

      „Endotropin ist möglicherweise der beste Biomarker für das kardiorenale Syndrom – aber noch wichtiger ist, dass es mehr als nur ein Biomarker ist. Es ist ein Ziel, das behandelt werden muss. Wir sehen darin eine neue Geschichte über TNF-alpha", sagte Morten Karsdal, Geschäftsführer von Nordic Bioscience.

      Referenz

      [1] Yoshiji S, Osawa I, Hill JA, Scherer PE, Audoly L. Adipokinachse bei Herzinsuffizienz: Endotrophin erfasst das fibroinflammatorische Risiko bei Erwachsenen mit Adipositas zusätzlich zu PREVENT und NT-proBNP. Auflage. 2026. AHA Scientific Sessions 2026, Abstract 6394.

      https://doi.org/10.1161/CIRC.154.SUPPL_1.6394 

      Informationen zu Nordic Bioscience

      Nordic Bioscience ist ein dänisches Biomarker-Unternehmen mit Hauptsitz in Herlev, Dänemark. Wir beschäftigen uns mit der Entwicklung von Biomarkern mit Schwerpunkt auf der extrazellulären Matrix (ECM) unter Verwendung unserer einzigartigen Neoepitop-Plattformtechnologie. Wir kombinieren unsere Expertise in der Biomarker-Entwicklung mit präklinischer und klinischer Forschung. Dadurch können wir Biomarker entwickeln, die eine schnelle und objektive Entscheidungsfindung für die Auswahl von Zusammensetzungen und Entwicklung in klinischen Studien bieten und gleichzeitig einen Nutzen für Patienten in einer diagnostischen Situation haben. Weitere Informationen zu Nordic Bioscience finden Sie unter https://www.nordicbioscience.com 

      Modal title

      Also from this source

      Roche Diagnostics met à disposition son prototype de test de recherche sur l'endotrophine chez Nordic Bioscience

      Roche Diagnostics met à disposition son prototype de test de recherche sur l'endotrophine chez Nordic Bioscience

      Nordic Bioscience a le plaisir d'annoncer que Roche Diagnostics met son prototype de test de recherche sur l'endotrophine (ETP) à disposition sur ses ...

      Roche Diagnostics pone a disposición de Nordic Bioscience un ensayo prototipo para investigar la endotrofina

      Roche Diagnostics pone a disposición de Nordic Bioscience un ensayo prototipo para investigar la endotrofina

      Nordic Bioscience se complace en anunciar que Roche Diagnostics pone a disposición su ensayo prototipo de investigación para la endotrofina (ETP) en...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Medical Equipment

      Medical Equipment

      Biotechnology

      Biotechnology

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.